시장보고서
상품코드
1574934

세계의 결핵 검사 시장 : 검사 유형별, 최종 사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율 예측(2024-2032년)

Tuberculosis Testing Market, By Test Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 284 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

2023년 결핵검사 시장 규모는 22억 9,032만 달러로 2024년부터 2032년까지 연평균 복합 성장률(CAGR) 5.99%로 확대

결핵 검사 시장 - 시장 역학

약물 내성 결핵균 증가가 검사 수요를 견인

약물 내성 결핵균 증가는 결핵 검사 시장의 중요한 촉진요인입니다. 이러한 내성 균주가 보편화됨에 따라 효과적인 치료를 위해서는 적시에 정확한 검사가 필수적입니다. 미국 질병 예방 관리 센터(CDC)에 따르면, 미국에서 새롭게 진단된 결핵 환자의 약 3%가 약물 내성입니다. 이 통계는 내성 균주를 확인하고 효과적으로 관리하기 위한 고급 검사 솔루션의 긴급한 필요성을 돋보이게 합니다. 건강 관리 제공업체는 적절한 치료를 보장하고 결핵의 확산을 억제하기 위해 신뢰할 수 있는 진단 도구가 필요합니다. 결핵에 대한 인식이 높아짐에 따라 혁신적인 검사 방법에 대한 수요는 계속 증가하고 시장 성장을 지원할 것으로 보입니다.

결핵 검사 시장 - 주요 인사이트

우리 리서치 애널리스트의 분석에 따르면 세계 시장은 예측 기간(2024-2032년)에 약 5.99%의 연평균 복합 성장률(CAGR)로 매년 성장할 것으로 추정됩니다.

검사 유형별로는 분자진단제가 2023년 최대 시장 점유율을 나타냈습니다.

최종 사용자별로 병리 검사실은 2023년의 주요 유형이었습니다.

지역별로는 북미가 2023년에 수익을 올리는 주요 시장이었습니다.

결핵 검사 시장 - 세분화 분석 :

세계의 결핵 검사 시장은 검사 유형, 최종 사용자 및 지역에 따라 세분화됩니다.

시장은 검사 유형별로 7가지 범주로 분류됩니다: X선 촬영법, 실험실 진단법, 분자진단법, 잠복 감염 검출, 사이토카인 검출 검정, 약물 내성 검출(DST), 파지 검정, 기타 검사 유형 . 결핵 검사 시장에서는 분자진단법, 특히 PCR(중합효소 연쇄반응) 방법이 가장 지배적인 분야입니다. PCR법은 소량의 균에서도 결핵균을 검출할 수 있는 속도와 정확도로 높게 평가되고 있습니다. 이 방법은 신속한 진단을 가능하게 하고 적시에 치료를 시작하고 질병의 확산을 억제하는 데 매우 중요합니다. 또한 약물 내성을 확인하는 능력도 치료 옵션을 확장합니다. 그 결과, PCR은 결핵 진단을 발전시키고 환자의 결과를 개선하는데 중요한 역할을 합니다.

시장은 최종 사용자별로 분류되어 있습니다 : 병리 검사실, POCT 등. 결핵 검사 시장에서는 병리 검사실이 가장 중요한 부문입니다. 이러한 검사실은 배양법이나 분자진단법을 포함한 다양한 검사를 실시하는데 필수적입니다. 병리 검사실은 많은 시료를 취급하고 결핵 진단 및 관리에 필수적인 정확한 결과를 제공할 수 있습니다. 전문 장비와 훈련받은 직원은 복잡한 검사를 정확하게 수행합니다. 결핵이 큰 건강 문제로 남아있는 동안, 병리 검사실의 역할은 매우 중요하며 시장의 주요 부문이되었습니다.

결핵 검사 시장 - 지리적 통찰

북미 결핵 검사 시장은 진보된 진단 기술에 초점을 맞추었습니다. 미국과 캐나다는 이 지역의 선두 주자이며 의료 및 조사에 많은 투자를 하고 있습니다. 미국에서는 질병대책예방센터(CDC)가 결핵검사와 예방을 추진하고 결핵에 대한 인식을 높이고 있습니다. 사례를 신속하게 확인하는 데 도움이 되는 분자진단과 같은 신속한 검사 방법의 요구가 증가하고 있습니다. 정부 프로그램 및 자금 지원은 특히 고위험 그룹을 대상으로 한 검사를 지원합니다. 시장의 주요 기업은 혁신을 추진하고 검사를 더 친숙하게 만들고 있습니다. 전반적으로 북미는 결핵 검사와 치료 노력을 향상시키는 데 중요한 역할을 합니다.

결핵 검사 시장 - 경쟁 구도:

결핵 검사 시장은 여러 주요 기업의 경쟁 구도이 특징입니다. Thermofisher Scientific과 Roche와 같은 기업들은 첨단 진단 도구를 제공함으로써 주도하고 있습니다. Abbott Laboratories와 BD는 결핵을 효과적으로 검출하기 위한 다양한 검사를 제공합니다. Cepheid는 빠른 분자 검사 솔루션으로 유명하며 인기가 점점 높아지고 있습니다.

Hologic와 QIAGEN도 검사 정밀도를 향상시키는 혁신적인 기술로 기여하고 있습니다. 다른 주요 기업은 특수 검사법에 특화된 BioMerieux 및 Oxford Immunotec이 있습니다. 이와 같이 다양한 제품을 제공함으로써 효율적인 결핵 진단에 대한 세계 수요 증가에 대응하고 있습니다.

목차

제1장 결핵 검사 시장 개요

  • 조사 범위
  • 시장추정년

제2장 주요 요약

  • 시장 분석
  • 경쟁 인사이트

제3장 결핵 검사의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장의 미래 동향

제4장 결핵 검사 산업의 조사

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 맵핑
  • 규제 틀 분석

제5장 결핵 검사 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 결핵검사 시장 상황

  • 결핵 검사 시장 점유율 분석, 2023년
  • 주요 제조업체별 분석 데이터
    • 기존 기업의 분석
    • 신흥 기업의 분석

제7장 결핵 검사 시장- 검사 유형별

  • 개요
    • 검사 유형별 부문 점유율 분석
    • 방사선학적 방법
    • 진단 검사법
      • 현미경 검사
      • 배양 기술적 검사
      • 혈청학적 검사
    • 분자진단
      • 중합효소 연쇄반응(PCR)
      • 핵산 증폭 검사(NAAT)
      • GeneXpert MTB/RIF
    • 잠재 감염 검출
      • 투베르쿨린 피부 테스트(TST)
      • 인터페론 감마 방출 분석(IGRA)
    • 사이토카인 검출 분석
    • 약제 내성 검출(DST)
    • 파지 분석
    • 기타

제8장 결핵 검사 시장- 최종 사용자별

  • 개요
    • 최종 사용자별 부문 점유율 분석
    • 병리학 연구실
    • 포인트 오브 케어 검사(POCT)
    • 기타

제9장 결핵검사시장-지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제10장 주요 벤더 분석-결핵 검사 업계

  • 경쟁 대시보드
  • 기업 프로파일
    • Thermo Fisher Scientific
    • Roche
    • Abbott Laboratories
    • BD(Becton, Dickinson and Company)
    • Hologic
    • Cepheid
    • QIAGEN
    • Molecular Testing Labs
    • Siemens Healthineers
    • Genomictree
    • BioMerieux
    • Oxford Immunotec
    • F. Hoffmann-La Roche AG
    • Eiken Chemical Co., Ltd.
    • Hain Lifescience GmbH

제11장 애널리스트의 전방위 전망

JHS 24.11.06

REPORT HIGHLIGHT

Tuberculosis Testing Market size was valued at USD 2,290.32 million in 2023, expanding at a CAGR of 5.99% from 2024 to 2032.

The tuberculosis (TB) testing market refers to the industry that provides various tests to diagnose TB, a serious infectious disease that mainly affects the lungs. This market includes different types of tests, such as skin tests, blood tests, and imaging tests like X-rays. The demand for TB testing has increased due to the rising number of TB cases worldwide and the need for early detection and treatment. Many organizations, including governments and health agencies, invest in TB testing to control the disease. Overall, the TB testing market plays a crucial role in public health by helping to identify and treat those affected by the disease.

Tuberculosis Testing Market- Market Dynamics

The increasing prevalence of drug-resistant tuberculosis strains drives testing demand.

The increasing prevalence of drug-resistant tuberculosis (TB) strains is a significant driver for the tuberculosis testing market. As these resistant strains become more common, timely and accurate testing is essential for effective treatment. According to the Centers for Disease Control and Prevention (CDC), about 3% of newly diagnosed TB cases in the U.S. are drug-resistant. This statistic highlights the urgent need for advanced testing solutions to identify and manage resistant strains effectively. Healthcare providers require reliable diagnostic tools to ensure appropriate treatment and control the spread of TB. As awareness grows, the demand for innovative testing methods will continue to rise, supporting market growth.

Tuberculosis Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.99% over the forecast period (2024-2032)

Based on Test Type segmentation, Molecular diagnostics was predicted to show maximum market share in the year 2023

Based on End-user segmentation, Pathological laboratories was the leading type in 2023

Based on Region, North America was the leading revenue generator in 2023

Tuberculosis Testing Market- Segmentation Analysis:

The Global Tuberculosis Testing Market is segmented based on Test Type, End User, and Region.

The market is divided into Seven categories based on Test Type: Radiographic method, Diagnostic laboratory methods, Molecular diagnostics, Detection of latent infection, Cytokine detection assay, Detection of drug resistance (DST), Phage assay, and other test types. In the tuberculosis testing market, Molecular diagnostics, particularly the Polymerase Chain Reaction (PCR) method, is the most dominant segment. PCR is highly valued for its speed and accuracy in detecting Mycobacterium tuberculosis, even in small amounts of bacteria. This method allows for quick diagnosis, which is crucial for initiating timely treatment and controlling the spread of the disease. Its ability to identify drug resistance also enhances treatment options. As a result, PCR plays a key role in advancing tuberculosis diagnostics and improving patient outcomes.

The market is divided into categories based on End Users: Pathological laboratories, Point of care testing (POCT), and Others. In the tuberculosis testing market, pathological laboratories are the most important segment. These labs are essential for performing various tests, including culture methods and molecular diagnostics. They can handle many samples and provide accurate results, which is vital for diagnosing and managing TB. Their specialized equipment and trained staff ensure that complex tests are done correctly. As TB continues to be a major health issue, the role of pathological laboratories is crucial, making them the leading segment in the market.

Tuberculosis Testing Market- Geographical Insights

The North American tuberculosis testing market focuses on advanced diagnostic technologies. The United States and Canada are the leaders in this region, with significant investments in healthcare and research. In the U.S., the Centers for Disease Control and Prevention (CDC) promotes TB testing and prevention, raising awareness about the disease. There is a growing need for rapid testing methods, like molecular diagnostics, which help identify cases quickly. Government programs and funding also support testing, especially for high-risk groups. Major companies in the market drive innovation and make testing more accessible. Overall, North America plays an important role in improving tuberculosis testing and treatment efforts.

Tuberculosis Testing Market- Competitive Landscape:

The tuberculosis testing market features a competitive landscape with several key players. Companies like Thermo Fisher Scientific and Roche lead in providing advanced diagnostic tools. Abbott Laboratories and BD offer a range of tests that help detect TB effectively. Cepheid is known for its rapid molecular testing solutions, which are becoming increasingly popular.

Hologic and QIAGEN also contribute innovative technologies to improve testing accuracy. Other notable players include BioMerieux and Oxford Immunotec, focusing on specialized testing methods. This diversity in offerings helps meet the growing demand for efficient tuberculosis diagnostics worldwide.

Recent Developments:

In November 2023, BD and Bio Farma signed a memorandum of understanding (MOU) to work together on addressing tuberculosis. BD offered access to its advanced TB diagnostic tools, while the partnership improved the supply chain for TB solutions in Indonesia.

In February 2023, Fisher Scientific launched real-time PCR kits in India for detecting various infectious diseases. These kits cover a range of conditions, including genetic analysis (HLA B27), Multi-Drug-Resistant Tuberculosis (MTB MDR), Hepatitis B Virus (HBV), M. Tuberculosis complex (MTB), Human Immunodeficiency Virus (HIV), and Hepatitis C Virus (HCV).

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL TUBERCULOSIS TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Thermo Fisher Scientific
  • Roche
  • Abbott Laboratories
  • BD (Becton, Dickinson, and Company)
  • Hologic
  • Cepheid
  • QIAGEN
  • Molecular Testing Labs
  • Siemens Healthineers
  • Genomictree
  • BioMerieux
  • Oxford Immunotec
  • F. Hoffmann-La Roche AG
  • Eiken Chemical Co., Ltd.
  • Hain Lifescience GmbH

GLOBAL TUBERCULOSIS TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Radiographic method
  • Diagnostic laboratory methods
  • Microscopy
  • Culture-based techniques
  • Serological tests
  • Molecular diagnostics
  • Polymerase chain reaction (PCR)
  • Nucleic acid amplification tests (NAAT)
  • GeneXpert MTB/RIF
  • Detection of latent infection
  • Tuberculin skin test (TST)
  • Interferon-gamma release assays (IGRAs)
  • Cytokine detection assay
  • Detection of drug resistance (DST)
  • Phage assay
  • Others

GLOBAL TUBERCULOSIS TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pathological laboratories
  • Point of care testing (POCT)
  • Others

GLOBAL TUBERCULOSIS TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Tuberculosis Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Tuberculosis Testing Market Snippet by Test Type
    • 2.1.2. Tuberculosis Testing Market Snippet by End User
    • 2.1.3. Tuberculosis Testing Market Snippet by Country
    • 2.1.4. Tuberculosis Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Tuberculosis Testing Key Market Trends

  • 3.1. Tuberculosis Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Tuberculosis Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Tuberculosis Testing Market Opportunities
  • 3.4. Tuberculosis Testing Market Future Trends

4. Tuberculosis Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Tuberculosis Testing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Tuberculosis Testing Market Landscape

  • 6.1. Tuberculosis Testing Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Tuberculosis Testing Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2023 & 2032 (%)
    • 7.1.2. Radiographic method
    • 7.1.3. Diagnostic laboratory methods
      • 7.1.3.1. Microscopy
      • 7.1.3.2. Culture-based techniques
      • 7.1.3.3. Serological tests
    • 7.1.4. Molecular diagnostics
      • 7.1.4.1. Polymerase chain reaction (PCR)
      • 7.1.4.2. Nucleic acid amplification tests (NAAT)
      • 7.1.4.3. GeneXpert MTB/RIF
    • 7.1.5. Detection of latent infection
      • 7.1.5.1. Tuberculin skin test (TST)
      • 7.1.5.2. Interferon-gamma release assays (IGRAs)
    • 7.1.6. Cytokine detection assay
    • 7.1.7. Detection of drug resistance (DST)
    • 7.1.8. Phage assay
    • 7.1.9. Others

8. Tuberculosis Testing Market - By End User

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 8.1.2. Pathological laboratories
    • 8.1.3. Point of care testing (POCT)
    • 8.1.4. Others

9. Tuberculosis Testing Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Tuberculosis Testing Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Tuberculosis Testing Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Tuberculosis Testing Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Tuberculosis Testing Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Tuberculosis Testing Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Tuberculosis Testing Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Thermo Fisher Scientific
    • 10.2.2. Roche
    • 10.2.3. Abbott Laboratories
    • 10.2.4. BD (Becton, Dickinson and Company)
    • 10.2.5. Hologic
    • 10.2.6. Cepheid
    • 10.2.7. QIAGEN
    • 10.2.8. Molecular Testing Labs
    • 10.2.9. Siemens Healthineers
    • 10.2.10. Genomictree
    • 10.2.11. BioMerieux
    • 10.2.12. Oxford Immunotec
    • 10.2.13. F. Hoffmann-La Roche AG
    • 10.2.14. Eiken Chemical Co., Ltd.
    • 10.2.15. Hain Lifescience GmbH

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제